Starting July 1, 2029, qualified doctoral-level psychologists may prescribe some mental health drugs for eligible patients under written agreements with psychiatrists.
Doctoral-level psychologists may qualify for a prescribing specialty after approved training, clinical rotations, and an exam. The Board’s Director may approve some applicants from other jurisdictions without an exam.
Psychologists with the specialty must work under a written agreement with a psychiatrist. Their authority covers some mental health drugs, with limits on eligible patients and controlled drugs.
The professional regulation office must report on the number of prescribing psychologists, access to collaborating practitioners, and whether qualification rules need changes.
The Board may grant a prescribing specialty to qualified doctoral-level psychologists. Applicants must hold a current Vermont doctoral-level psychology license, complete approved postdoctoral psychopharmacology training, complete at least 14 months of clinical rotations in at least five settings, and pass a national exam, among other requirements. Applicants must meet the Board’s requirements and pay any required fee. The Board’s Director may grant the specialty without an exam to applicants with active prescribing authority elsewhere if the Director finds that jurisdiction’s requirements substantially equivalent. These provisions take effect July 1, 2029.
A prescribing psychologist must prescribe under a written agreement with a collaborating psychiatrist. Prescribing authority covers diagnosing, treating, or managing a condition recognized in the current Diagnostic and Statistical Manual of Mental Disorders. It excludes people under 18, over 80, or pregnant, and does not include dispensing, administering, or distributing prescription drugs. The psychiatrist may authorize only mental health drugs they generally provide to their own patients. The psychiatrist must file the agreement with the Board and notify it if the agreement ends. For Schedule II–V controlled drugs, the agreement must name the specific drug. Psychologists may not prescribe or give controlled drugs by injection. These provisions take effect July 1, 2029.
The Office of Professional Regulation must report to two legislative committees about prescribing psychologists. The report goes to the House Committee on Health Care and the Senate Committee on Health and Welfare. The report must cover the number of psychologists with the specialty, access to collaborating practitioners, and whether qualification rules need updates to balance access and public protection. The report is due on or before November 15, 2032.
No hearings or votes scheduled.